About Montgomery Pharmaceuticals

A Canadian pharmaceutical company built on scientific rigor, ethical practice, and an unwavering commitment to advancing regenerative medicine.

Empowering Healthcare Through Science

Montgomery Pharmaceuticals was founded with a singular purpose: to bridge the gap between groundbreaking regenerative science and accessible, clinically applicable therapies for Canadian patients.

Based in Maple Ridge, British Columbia, we develop, manufacture, and distribute pharmaceutical-grade peptide and stem cell solutions that empower healthcare professionals to deliver transformative outcomes.

We believe the future of medicine lies in the body's own regenerative potential — and we're dedicated to unlocking it safely, ethically, and effectively.

2009
Year Founded in Maple Ridge, BC
200+
Healthcare Partner Clinics
50+
Unique Therapeutic Compounds
15+
Years of Research & Development

What We Stand For

Every decision we make is guided by a core set of values that define how we operate, innovate, and serve.

🔬

Scientific Integrity

We only bring products to market that are backed by peer-reviewed research and validated through rigorous testing.

🤝

Practitioner Partnership

We see ourselves as an extension of the clinical teams we serve. Our support doesn't end at the point of sale — it begins there.

🛡️

Patient Safety First

Every protocol, product specification, and supply chain decision is evaluated through the lens of patient safety and regulatory compliance.

🌱

Ethical Innovation

We pursue innovation responsibly — following ethical sourcing practices, sustainable manufacturing, and transparent communication.

🇨🇦

Canadian Excellence

Proudly Canadian. We prioritize domestic sourcing, local partnerships, and adherence to Health Canada's highest standards.

📚

Education & Transparency

We invest heavily in practitioner education and public awareness, ensuring the science is accessible and clearly communicated.

Meet the Experts Behind Montgomery Pharmaceuticals

Our team combines decades of experience in pharmaceutical sciences, clinical medicine, and regenerative biology.

👨‍⚕️

Dr. Michael Chen, PhD

Chief Executive Officer & Co-Founder

Former research director at UBC's Centre for Blood Research, Dr. Chen holds a PhD in Biochemistry with 20+ years of experience in peptide synthesis and regenerative medicine development.

👩‍🔬

Dr. Sarah Okonkwo, MD

Chief Medical Officer

Board-certified in internal medicine and fellowship-trained in regenerative medicine, Dr. Okonkwo oversees clinical protocols, physician education, and patient safety frameworks.

🧬

Dr. Raj Patel, PhD

Director of Research & Development

A cell biology specialist from SFU with expertise in stem cell differentiation and exosome isolation, Dr. Patel leads our product development pipeline and quality assurance programs.

👩‍💼

Lisa Nakamura, PharmD

Director of Regulatory Affairs

With 15 years at Health Canada and in private pharmaceutical practice, Lisa ensures all products and processes meet Canadian federal regulatory requirements.

👨‍🏭

James Kowalski

Head of Manufacturing & Quality Control

A GMP specialist with ISO certification expertise, James oversees our production facility in Maple Ridge, ensuring every batch meets the highest standards of purity.

👩‍💻

Dr. Amara Thompson

Medical Science Liaison Lead

Dr. Thompson coordinates our practitioner education programs, clinical support services, and CME partnerships across British Columbia.

🏭

Our Maple Ridge Facility

State-of-the-art ISO Class 7 clean room manufacturing in the heart of Maple Ridge, BC.

ISO 7
Clean Room Class
GMP
Certified Process
HC
Health Canada Registered
3rd Party
Verified Testing

Built on a Foundation of Quality

Our production facility in Maple Ridge adheres to the strictest Good Manufacturing Practice (GMP) standards, as required by Health Canada.

1

Raw Material Sourcing

All precursor materials are sourced from certified Canadian and international suppliers with full traceability documentation.

2

Synthesis & Formulation

Peptides are synthesized using solid-phase peptide synthesis (SPPS) in ISO-controlled environments. Stem cell derivatives are processed under sterile bioreactor conditions.

3

Quality Control Testing

Every batch undergoes HPLC analysis, mass spectrometry, sterility testing, and endotoxin assay before release.

4

Cold Chain Distribution

Products are packaged and distributed under validated cold-chain conditions to ensure potency upon delivery to your practice.

Join Our Growing Network

Become a Montgomery Pharmaceuticals partner clinic and gain access to our full product range, clinical protocols, and dedicated support team.